News
Cancer drug significantly cuts risk for COVID-19 death
The data are “pretty impressive and in a group of patients that we really have limited things to offer.”
News
Three things to know about insurance coverage for abortion
The question of whether an insurance plan covers abortion is not the same as whether abortion is allowed in a state. Coverage issues are more...
News
Study eyes characteristics of pediatric patients with hidradenitis suppurativa
Obesity was the most common comorbidity at the time of diagnosis, with 64% of patients affected.
News
IBD in pregnancy: Ustekinumab, vedolizumab use appears safe
There were no significant differences in pregnancy outcomes and no negative safety signals in postnatal outcomes.
News
Feds warn pharmacists: Don’t refuse to provide abortion pills
The HHS listed several conditions that are commonly treated with drugs that can induce abortion, warning that withholding the pills could violate...
News
New algorithm can ID critical cancer mutations in DNA
“We’ve taken something that’s really complex and summarized that into a catalog, or a blueprint.”
Article
Hidradenitis Suppurativa: Workup
News
Shift schedule today could worsen that stroke tomorrow
Plus: Feed your soul with online art, feed your “hangry” etymologist, but don’t feed anyone with SARS-CoV-2 from the freezer.
News
In the quest for a cure for type 1 diabetes, two companies merge
The type 1 diabetes advocacy organization JDRF said the acquisition “represents a significant stride in cures research for the type 1 diabetes...
News
Quicker remission with tofacitinib versus vedolizumab in ulcerative colitis: study
Tofacitinib achieves higher clinical and biochemical remission rates than vedolizumab for patients with anti–TNF-exposed ulcerative colitis,...